In the wake of GlaxoSmithKline's (GSK) exit from Nigeria in August 2023, the nation has witnessed an alarming surge in the cost of drugs and pharmaceuticals. This unprecedented increase has far-reaching implications, widening the social gap and restricting access to healthcare for many...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.